Ignite Creation Date:
2025-12-24 @ 3:15 PM
Ignite Modification Date:
2026-01-23 @ 5:35 AM
Study NCT ID:
NCT03405792
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-10-28
First Post:
2018-01-12
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study Testing The Safety and Efficacy of Adjuvant Temozolomide Plus TTFields (Optune®) Plus Pembrolizumab in Patients With Newly Diagnosed Glioblastoma (2-THE-TOP)
Sponsor:
University of Florida
Organization: